Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: A preliminary study

Climacteric

Volumn 8, Issue 3, 2005, Pages 243-250

  Nedstrand, E ^a,b   Wijma, K ^a   Wyon, Y ^a   Hammar, M ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acupuncture; Applied relaxation; Breast cancer; Menopause; Vasomotor symptoms

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROACUPUNCTURE; FEMALE; FOLLOW UP; HOT FLUSH; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; VASOMOTOR DISORDER;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ELECTROACUPUNCTURE; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RELAXATION TECHNIQUES; TAMOXIFEN;

EID: 24144440474     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130500118050     Document Type: Article

References (41)

1. Stenbeck M. Breast. Acta Oncol 1995;34(Suppl 4):49-51
2. Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43
3. Persson I, Bergström R, Barlow L, Adami H-O. Recent trends in breast cancer incidence in Sweden. Br J Cancer 1998;77:167-9
4. Million Women Study collaboration. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-27
5. Love RR, Cameron L, Connell B, Levanthal H. Symptoms associated with tamoxifene treatment in postmenopausal women. Arch Intern Med 1991;151:1842-7
6. Coup R, Helzlouer K, Petting J. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737-44
7. Seifert M, Galid A, Kubista E. Estrogen replacement therapy in women with a history of breast cancer. Maturitas 1999;32:63-8
8. Holmberg L, Andersson H. HABITS (hormonal replacement therapy after breast cancer - is it safe? A randomised comparison: trial stopped. Lancet 2004;363:453-5
9. Freedman RR, Woodward S. Behavioural treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436-9
10. Hunter M, Liao KLM. Evaluation of a four session cognitive-behavioural intervention for menopausal hot flushes. Br J Health Psychol 1996;1:113-25
11. Wyon Y, Lindgren R, Lundeberg T, Hammar M. Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal women. Menopause 1995;2:3-12
12. Loprinzi C, Kugler J, Sloan J, et al. Venlaxafine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;365:2059-63
13. Wijma K, Melin A, Nedstrand E, Hammar M. Treatment of menopausal symptoms with applied relaxation: a pilot study. J Behav Ther Exp Psychiatry 1997;28:251-64
14. Freedman RR, Woodward S, Sabharwal SC. α-2 adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 1990;76:573-8
15. Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990;252:696-705
16. Andersson S, Lundeberg T. The functional background in acupuncture effects. Scand J Rehabil Med 1993;Suppl 29:31-60
17. Andersson S, Lundeberg T. Acupuncture - from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 1995;45:271-81
18. Thomas M, Lundeberg T. Importance of modes of acupuncture in the treatment of chronic nociceptive low back pain. Acta Anaesth Scand 1994;38:63-9
19. Carlsson C, Sjölund B. Acupuncture and subtypes of chronic pain: assessment of long-term results. Clin J Pain 1994;10:290-5
20. Lement-Jones V, McLloughlin L, Tomlin S, Besser G, Rees L, Wen H. Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 1980;2:946-9
21. Zhang A, Xiaoping P, Shaofen X, Jieshi C, Wanying M. Endorphins and acupuncture analgesia. Chin Med J 1980;93:673-80
22. Cumming D, Wheeler G. Opioids in exercise physiology. In Speroff L, Lobo R, eds. Role of Opioid Peptides in Reproductive Endocrinology. Seminars in Reproductive Endocrinology, Vol 5, No 2. New York: Thieme Medical Publishers, 1987:171-9
23. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990;69:409-12
24. Ivarsion T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998;29:139-46
25. Wiklund I, Holst J, Karlberg J, Mattsson L-Å, Samsioe G, Uvebrandt M, von Schoultz B. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 1992;14:211-24
26. Öst LG. Applied relaxation: description of a coping technique and review of controlled studies. Behav Res Ther 1987;25:397-409
27. Sandkuehler J, Chen J, Cheng G, Randic M. Low frequency stimulation of afferent Aδ?fibers induces long-term depression of primary afferent synapses with substantia gelatinosa neurons in the rat. J Neurosci 1997;17:6483-91
28. De Quattro V, Lee D, Shkhvatsabaya I, et al. Primary hypertension: left ventricular mass and function, sympathetic nervous system activity and therapy. Health Psychol 1988;7:165-73
29. Tepper R, Neri A, Kaufman H, Schoenfeld A, Ovadia J. Menopausal hot flushes and plasma β-endorphins. Obstet Gynecol 1987;70:150-2
30. Shoupe D, Lobo R. Endogenous opioids in the menopause. In Speroff L, Lobo R, eds. Role of Opioid Peptides in Reproductive Endocrinology. Seminars in Reproductive Endocrinology, Vol 5, No2. New York: Thieme Medical Publishers, 1987:199-206
31. Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990;252:696-705
32. Freedman R, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flushes. Am J Obstet Gynecol 1999;181:66-70
33. Uvnäs-Mobärg K, Bruzelius G, Alster P, Lundeberg T. The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms. Acta Physiol Scand 1993;149:199-204
34. Uvnäs-Mobärg K. Physiological and endocrine effects of social contact. Ann NY Acad Sci 1997;907:146-63
35. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978;2:654-7
36. Ter Riet G, de Craen A, de Boer A, Kessels A. Is placebo analgesia mediated by endogenous opioids? A systemic review. Pain 1998;76:273-5
37. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapies versus placebo for hot flushes (Cochrane Review). In The Cochrane Library, Issue 2, 2001. Oxford Update Software
38. Cohen FJ, Lu Y. Characterization of hot flushes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials. Maturitas 1999;34:65-73
39. Sloan J, Loprinzi C, Novotny P, Barton D, Lavasseur B, Windschitl H. Methodological lessons learned from hot flash studies. J Clin Oncol 2001;23:4280-90
40. Freedman RR. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 1989;26:573-9
41. McKinlay S, Brambilla D, Posner J. The normal menopause transition. Maturitas 1992;14:103-15